POST Online Media Lite Edition


Stryker Corporation adds Roch Doliveux to the board

Staff writer |
Kalamazoo, Mich., USA - June 23, 2010, Kalamazoo, Mich., USA - Stryker Corporation, a medical technology company, announced the election of Roch Doliveux as a director.

Article continues below

Dr. Doliveux has served since 2005 as Chief Executive Officer and Chairman of the Executive Committee of UCB S.A., a global biopharmaceutical company.

Dr. Doliveux has previously been a Chief Executive Officer of Pierre Fabre Pharmaceuticals and President, Schering-Plough International, a subsidiary of Schering-Plough Corporation.


What to read next

Medovex appoints Ron Lawson to board of directors
Parker elects Stryker CEO Kevin Lobo to board
CONMED appoints Curt Hartman as president and CEO